News
Clinical Infectious Disease s has launched a new series that will provide an in-depth look at real-life complex cases and the associated diagnostic and management decisions that ID clinicians deal ...
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
The combination of nivolumab with ipilimumab was approved for unresectable or metastatic microsatellite instability-high (MSI ...
Learn more› By Elissa Sanci Elissa Sanci is a senior writer who has reported on label makers, tumblers, and more. She once dumped glitter in her car to test handheld vacuums. A label maker has ...
Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.
Pneumonia in the Shadow of COVID-19: Along Came COVID Infectious disease experts describe ways in which COVID pneumonia differs from community-acquired pneumonia and how COVID vaccines may offer ...
This title is part of a longer publication history. The full run of this journal will be searched. TITLE HISTORY A title history is the publication history of a journal and includes a listing of the ...
While hardcore NFL Draft fans have read the mocks, checked the big boards, and settled into the generally accepted rhymes and rhythms of where teams will select certain players, all it takes is ...
The humerus is your upper arm bone. It is the longest bone in the upper part of your body and is connected to many important tendons and ligaments. The top of the humerus is part of the shoulder joint ...
eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results